Charles W. Newhall III - Nov 16, 2023 Form 4 Insider Report for SUPERNUS PHARMACEUTICALS, INC. (SUPN)

Role
Director
Signature
/s/ Timothy C. Dec, as attorney-in-fact
Stock symbol
SUPN
Transactions as of
Nov 16, 2023
Transactions value $
-$1,122
Form type
4
Date filed
11/20/2023, 05:00 PM
Previous filing
Feb 27, 2023
Next filing
Feb 26, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SUPN Common Stock Options Exercise $68.9K +7.46K +6.65% $9.24 120K Nov 16, 2023 Direct
transaction SUPN Common Stock Sale -$70K -2.5K -2.09% $28.01 117K Nov 16, 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction SUPN Director Stock Option (Right to Buy) Options Exercise $0 -7.46K -100% $0.00* 0 Nov 16, 2023 Common Stock 7.46K $9.24 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents the number of shares of common stock sold to cover the exercise price of the employee stock options.